Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 260 (RNA5SP260)

Target
RNA5SP260
Molecular classification
Other, Pseudogene, Ribosomal RNA pseudogene, Processed pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 260 (RNA5SP260) is a processed pseudogene related to the 5S ribosomal RNA gene family[2]. 5S rRNA genes encode a highly conserved ~120-nucleotide RNA that forms a core structural and functional component of large ribosomal subunits in all domains of life except some mitochondria[1][5]. Pseudogenes such as RNA5SP260 arise through duplication or retrotransposition events, but accumulate mutations that render them incapable of producing functional RNA or protein[4]. There is no evidence that RNA5SP260 is transcribed, nor is it associated with any regulatory, disease, or pharmacological activity. RNA5SP260 is an inactive pseudogene, not a functional drug target or receptor, and has no known biological or disease roles, drug interactions, or clinical relevance beyond its annotation in genomic databases[2][4].

Other names
RN5S260RNA, 5S ribosomal 260RNA5SP260
02

Mechanism of action

None

03

Biological functions

None established
04

Disease associations

None documented

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 260 (RNA5SP260).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 260 (RNA5SP260).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call